CA1023662A - Vaccin hb ag a forte production d'anticorps - Google Patents

Vaccin hb ag a forte production d'anticorps

Info

Publication number
CA1023662A
CA1023662A CA206,978A CA206978A CA1023662A CA 1023662 A CA1023662 A CA 1023662A CA 206978 A CA206978 A CA 206978A CA 1023662 A CA1023662 A CA 1023662A
Authority
CA
Canada
Prior art keywords
antibody productivity
vaccine high
vaccine
antibody
productivity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA206,978A
Other languages
English (en)
Inventor
Tsunekazu Fukushima
Satoshi Funakoshi
Toshihiko Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Green Cross Corp Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Japan filed Critical Green Cross Corp Japan
Application granted granted Critical
Publication of CA1023662A publication Critical patent/CA1023662A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
CA206,978A 1974-01-28 1974-08-14 Vaccin hb ag a forte production d'anticorps Expired CA1023662A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1161774A JPS5523254B2 (fr) 1974-01-28 1974-01-28

Publications (1)

Publication Number Publication Date
CA1023662A true CA1023662A (fr) 1978-01-03

Family

ID=11782869

Family Applications (1)

Application Number Title Priority Date Filing Date
CA206,978A Expired CA1023662A (fr) 1974-01-28 1974-08-14 Vaccin hb ag a forte production d'anticorps

Country Status (6)

Country Link
JP (1) JPS5523254B2 (fr)
CA (1) CA1023662A (fr)
CH (1) CH617350A5 (fr)
DE (1) DE2440926C3 (fr)
FR (1) FR2258864B1 (fr)
GB (1) GB1462298A (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4017360A (en) * 1975-05-14 1977-04-12 Merck & Co., Inc. Method for purifying hepatitis B antigen
GB1571829A (en) 1976-04-06 1980-07-23 Lafon Labor Sulphur-containing diaryl compounds and oxygen-containing diaryl compounds
JPS591981B2 (ja) * 1976-08-27 1984-01-14 株式会社ミドリ十字 ＨＢｓ抗体検出用受身赤血球凝集試験用担体の製造方法
US4639371A (en) * 1984-10-02 1987-01-27 New York Blood Center, Inc. Hepatitis B antigenic compositions and vaccines against hepatitis B derived therefrom

Also Published As

Publication number Publication date
JPS50105817A (fr) 1975-08-20
CH617350A5 (en) 1980-05-30
FR2258864A1 (fr) 1975-08-22
DE2440926B2 (de) 1978-04-06
JPS5523254B2 (fr) 1980-06-21
GB1462298A (en) 1977-01-19
DE2440926C3 (de) 1978-11-30
FR2258864B1 (fr) 1978-06-30
DE2440926A1 (de) 1975-07-31

Similar Documents

Publication Publication Date Title
AU518663B2 (en) Cancer associated protein
AU499816B2 (en) Multile panes
CA1025060A (fr) Dispositif de continuite electrique
CA1022050A (fr) Conditionnement et methode connexe
CA1016673A (en) Boronometer improvement
CA1012377A (en) High chair spacer
CA1023662A (fr) Vaccin hb ag a forte production d'anticorps
CA1030066A (fr) Antigene tetanique et procede de fabrication
CA1030062A (fr) Methode hydraulique de fractionnement
AU494978B2 (en) Table
AU503647B2 (en) Antipregnancy vaccine
SU638412A1 (ru) Способ получени изделий
AU460424B2 (en) Wine and spirit production
AU483628B1 (en) Process
AU492353B1 (en) Improvements in saws
AU485292B2 (en) Tricycle
AU8381075A (en) Nor-cycloalkyl-13, 14-dehydro-prostaglandins and process for their preparation
AU491929B2 (en) Pgf - prostaglandins and process for their preparation
CA1020360A (en) Flocculation-desliming process
AU489628B2 (en) Cinnoline derivatives
CA884067A (en) Cut-off tool
AU484040B2 (en) Methods
AU490115B2 (en) Tipping frame
AU460089B2 (en) Anovel polyhalopropanol
CA1025061A (fr) Appareil de fusionnement